Prospectus Prospectus dated October 20, 2025 13.6 MB Supplement dated November 11, 2025 1.2 MB Exemption Document Exemption Document dated October 20, 2025 10.4 MB Update dated November 11, 2025 1.6 MB Available Documents Q3 Unaudited Interim Condensed Consolidated Financial Statements of BioNTech SE 732.3 KB Articles of Association of BioNTech SE (German) 1 MB Articles of Association of BioNTech SE (English translation) 184.3 KB Purchase Agreement 1.8 MB Form of Tender and Support Agreement 432 KB Form of Deposit Agreement between BioNTech SE, The Bank of New York Mellon as depositary and owners and holders of BioNTech ADSs 703.8 KB Form of Letter of Transmittal 106.4 KB Form of Notice of Withdrawal 42.1 KB Q2 Unaudited Interim Condensed Consolidated Financial Statements of BioNTech SE 1.1 MB Audited Consolidated Financial Statements of BioNTech SE 2024 2.3 MB Audited Consolidated Financial Statements of BioNTech SE 2023 1.6 MB Audited Consolidated Financial Statements of BioNTech SE 2022 1.6 MB Audited Annual Financial Statements of BioNTech SE 2024 1.1 MB CureVac Audited Consolidated Financial Statements 2024, 2023 and 2022 3 MB CureVac Q2 Unaudited Interim Condensed Consolidated Financial Statements
Q3 Unaudited Interim Condensed Consolidated Financial Statements of BioNTech SE 732.3 KB Articles of Association of BioNTech SE (German) 1 MB Articles of Association of BioNTech SE (English translation) 184.3 KB Purchase Agreement 1.8 MB Form of Tender and Support Agreement 432 KB Form of Deposit Agreement between BioNTech SE, The Bank of New York Mellon as depositary and owners and holders of BioNTech ADSs 703.8 KB Form of Letter of Transmittal 106.4 KB Form of Notice of Withdrawal 42.1 KB Q2 Unaudited Interim Condensed Consolidated Financial Statements of BioNTech SE 1.1 MB Audited Consolidated Financial Statements of BioNTech SE 2024 2.3 MB Audited Consolidated Financial Statements of BioNTech SE 2023 1.6 MB Audited Consolidated Financial Statements of BioNTech SE 2022 1.6 MB Audited Annual Financial Statements of BioNTech SE 2024 1.1 MB CureVac Audited Consolidated Financial Statements 2024, 2023 and 2022 3 MB CureVac Q2 Unaudited Interim Condensed Consolidated Financial Statements
